Amine Accumulation: A Possible Precursor of Lewy Body Formation in Parkinson's Disease

References

• Agnoli A., Ruggieri S., Falaschi P. A neuropharmacological and neuroendocrine study on idiopathic and chronic pharmacological parkinsonism. Advances in Biochemical Psychopharmacology 1980; 24: 551–557
   PubMedGoogle Scholar
• Alvord E. C. The pathology of Parkinsonism: Part II. An interpretation with special reference to other changes in the aging brain. Recent Advances in parkinson's disease, F. H. McDowell, C. H. Markham. Davis, Philadelphia 1971
   Google Scholar
• Anden N. E., Dahlstrom A., Fuxe K., Larsson K. Further evidence for the presence of nigrostrialal dopamine neurons in the rat. American Journal of Anatomy 1965; 116: 329–334
   PubMedGoogle Scholar
• Appenzeller O., Goss J. E. Autonomic deficits in Parkinson's disease. Archives of Neurology 1971; 24: 50–57
   PubMedGoogle Scholar
• Askenasy J. J. M., Yahr M. D. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 1985; 35: 527–532
   PubMed Web of Science ®Google Scholar
• Barbeau A. Parkinson's disease: etiological considerations. The basal ganglia, M. D. Yahr. Raven Press, New York 1976; 281–292
   Google Scholar
• Beheim‐Schwartzbach D. Ueber Zelleib‐Varanderungen im Nucleus Coeruleus bo in Parkinson‐Syinptomen. Journal of Nervous and Mental Disease 1952; 116: 619–632
   PubMed Web of Science ®Google Scholar
• Berk M. L., Finkelstein J. A. Efferent connections of the lateral hypothalamic area of the rat: An autoradiographic investigation. Brain Research Bulletin 1982; 8: 511–526
   PubMed Web of Science ®Google Scholar
• Bernheimer H., Birkmayer W., Hornykiewicz O. Verteilung des 5‐hydroxytryptamins (Serotonin) in Gehirn des Menschen und sein Verhalten bein Patienlen mit Parkinson Syndrome. Klinische Wochenschiift 1961; 39: 1056–059
   PubMedGoogle Scholar
• Birkmayer W. Medical treatment of Parkinson's disease: general review, past and present. Advances in parkinsonism, W. Birkmayer, O. Hornykiewicz. Roche, Basle 1976; 407–423
   Google Scholar
• Birkmayer W., Mentasi M. Weitere experimented Untersuchungen uber den Katecholaminstoffwechsel bein extrapyramidalen Erkrankungen (Parkinson‐und Chorea syndrome). Archives Psychiatrie und Nervenkrankheiten 1967; 210
   Google Scholar
• Birkmayer W., Jellinger K., Riederer P. Striatal and extrastriatal functions. Psychobiology of the striatum, A. R. Cools, H. M. Lohman, J. H. L. Van den Bercken. North Holland, Amsterdam 1977; 141–153
   Google Scholar
• Birkmayer W., Danielczyk W., Neumacher E., Riederer P. Nucleus ruber and L‐dopa psychosis: biochemical postmortem findings. Journal of Neural Transmission 1974; 35: 93–116
   PubMed Web of Science ®Google Scholar
• Birkmayer W., Danielczyk W., Neumayer E., Riederer P. Dopamine supersensitivity in Parkinsonism. Advances in neurology, D. B. Calne, T. N. Chase, A. Barbeau. Raven Press, New York 1975; 121–129
   Google Scholar
• Boiler F., Mizutani T., Roessmann U., Gambetti P. Parkinson's disease, dementia and Alzheimer's disease: clinicopathological correlations. Annals of Neurology 1980; 7: 329–335
   PubMedGoogle Scholar
• Boiler F., Passafiume D., Keefe N. C. Visuospatial impairment in Parkinson's disease: role of perceptual and motor factors. Archives of Neurology 1984; 41: 485–490
   PubMedGoogle Scholar
• Bonuccelli U., Piccini P., Napolitano A., Cagnacci A., Paoletti A. M., Melis G. B., Muratorio A. Reduced luteinizing hormone secretion in women with Parkinson's disease. Journal of Neural Transmission 1990; 2: 225–231
   Google Scholar
• Bowers M. B., Van Woert M., Davis L. Sexual behavior during L‐dopa treatment for Parkinsonism. American Journal of Psychiatry 1971; 127: 1691–1693
   PubMed Web of Science ®Google Scholar
• Brooks C. MoC. The history of thought concerning the hypothalamus and its functions. Brain Research Bulletin 1988; 20: 657–667
   PubMedGoogle Scholar
• Brown E., Brown G. M., Kofman O., Quarrington B. Sexual function and affect in parkinsonian men treated with L‐dopa. American Journal of Psychiatry 1978; 135: 1552–1555
   PubMed Web of Science ®Google Scholar
• Burton J. L., Cartlidge M., Cartlidge N. E. F., Suster S. Sebum secretion in Parkinsonism. British Journal of Dermatology 1973; 88: 263–266
   PubMed Web of Science ®Google Scholar
• Butterworth R. F., Belanger F., Barbeau A. Hypokinesia produced by anterolateral hypothalamic 6‐hydroxydopamine lesions and its reversal by some antiparkinson drugs. Pharmacology Biochemistry, & Behavior 1978; 8: 41–45
   PubMed Web of Science ®Google Scholar
• Cagnacci A., Bonuccelli U., Melis G. B., Soldani R., Piccini P., Napolitano A., Muratorio A., Fioretti P. Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. Life Sciences 1990; 46: 1241–1247
   PubMedGoogle Scholar
• Cagnacci A., Melis G. B., Soldani R., Bonuccelli U., Piccini P., Napolitano A., Muratorio A., Fioretti P. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. Neuroendocrinology 1991; 53: 549–555
   PubMedGoogle Scholar
• Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet 1983; 2: 1457–1459
   PubMedGoogle Scholar
• Calne D. B., Brennan J., Spiers A. S. D., Stern G. M. Hypotension caused by L‐dopa. British Medical Journal 1970; 1: 474–475
   PubMed Web of Science ®Google Scholar
• Camerlingo M., Aillon C., Bottacchi E., Gambaro P., D'Alessandro G., Franceschi M., Devoti G., Mamoli A. Parasympathetic assessment in Parkinson's disease. Advances in Neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 267–269
   Google Scholar
• Carpenter M. B. Core text of neuroanatomy. Williams, & Wilkins, Baltimore 1985; 265–288
   Google Scholar
• Chiba T., Jew J. Y., Williams T. H. Ultrastructural evidence for remodelling in a central noradrenergic pathway following electrolytic lesioning. Brain Research 1979; 171: 77–83
   PubMedGoogle Scholar
• Conte‐Devolx B., Grino M., Nieoullon A., Javoy‐Agid F., Castanas E., Guillaume V., Tonon M. C., Vaudry H., Oliver C. Corticoliberin, somatocrinin and amine contents in normal and Parkinsonian human hypothalamus. Neuroscience Letters 1985; 56: 217–222
   PubMed Web of Science ®Google Scholar
• Dahlstrom A., Fuxe K. A method for the demonstration of monoamine‐containing nerve fibres in the central nervous system. Acta Physiologica Scandinavica 1964; 60: 293–299
   PubMedGoogle Scholar
• Den Hartog W. A., Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopalhic paralysis agitans. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 283–290
   PubMedGoogle Scholar
• De Remigis P. L., Damiani A., Vianale L., Gambi D., Aquilone L., Liberatoscioli C., Menduni P., Sensi S. Circadian study of PRL and TSH in subjects affected by Parkinson's disease before and after treatment with bromocriptin. Chronobiologia 1983; 10: 121
   Google Scholar
• De Smet Y., Ruberg M., Serdaru M., Dubois B., Lhermitte F., Agid Y. Confusion, dementia and anticholinergics in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1982; 45: 1161–1164
   PubMed Web of Science ®Google Scholar
• Dickson D. W., Davies P., Mayeux R., Crystal H., Horoupian D. S., Thompson A., Goldman J. E. Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathologica (Berlin) 1987; 75: 8–15
   PubMed Web of Science ®Google Scholar
• Ditter S. M., Mirra S. S. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37: 754–760
   PubMedGoogle Scholar
• Eisler T., Thorner M. O., MacLeod R. M., Kaiser D. L., Calne D. B. Prolactin secretion in Parkinson's disease. Neurology 1981; 31: 1356–1359
   PubMedGoogle Scholar
• Ehringer H., Hornykiewicz O. Verteilung von Noradrenalin und Dopamine (3‐Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalar Systems. Wien Klinischer Wochenschrift 1960; 38: 1236–1239
   Web of Science ®Google Scholar
• Elizan T. S., Sroka H., Maker H., Smith H., Yahr M. D. Dementia in idiopathic Parkinson's disease. Variables associated with its occurrence in 203 patients. Journal of Neural Transmission 1986; 65: 285–302
   PubMedGoogle Scholar
• Elliot K., Cote L. J., Frewir D. B. Vascular responses in the hands of Parkinson's disease patients. Neurology 1974; 24: 857–862
   PubMedGoogle Scholar
• Farley I. J., Hornykiewicz O. Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. Advances in parkinsonism. Roche, Basel 1976; 178–185
   Google Scholar
• Figa‐Talamanca L., Gualandi C., Di Meo L., Di Battista G., Neri G., Lo Russo F. Hyperthermia after discontinuation of levodopa and bromocriptine therapy: impaired dopamine receptors as a possible cause. Neurology 1985; 35: 258–261
   PubMed Web of Science ®Google Scholar
• Fink J. S., Smith G. P. L‐dopa repairs deficits in locomotor and investigatory exploration produced by denervation of catecholamine terminal fields in the forebrain of rats. Journal of Comparative and Physiological Psychology 1979; 93: 66–73
   PubMedGoogle Scholar
• Fliers E., Swaab D. F., Pool C. W., Verwer R. W. H. The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia. Brain Research 1985; 342: 45–53
   PubMedGoogle Scholar
• Forno L. S. Pathology of parkinsonism: a preliminary report of 24 cases. Journal of Neurosurgery 1966; 24: 266–271, (suppl)
   Web of Science ®Google Scholar
• Forno L. S. Concentric hyaline inlraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. Journal of The American Geriatric Society 1969; 17: 557–575
   PubMed Web of Science ®Google Scholar
• Forno L. S. The Lewy body in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 35–43
   Google Scholar
• Fomo L. S. Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. Parkinson's disease, G. Stern. Chapman and Hall, London 1990; 185–238
   Google Scholar
• Forno L. S., Norville R. L. Ultrastructure of Lewy bodies in the hypothalamus and dorsal motor vagus nucleus. Journal of Neuropathology and Experimental Neurology 1977; 36: 602
   Google Scholar
• Forno L. S., Barbour P. J., Norville R. L. Presenilc dementia with Lewy bodies and neurofibrillary tangles. Archivrs of Neurology 1978; 35: 818–822
   PubMedGoogle Scholar
• Franceschi M., Cecchetto R., Panerai A. E., Truci G., Smirne S., Canal N. Plasma betaendorphin and beta‐lipotropin in patients with Parkinson's disease. Clinical Neuropharmacology 1986; 9: 549–555
   PubMed Web of Science ®Google Scholar
• Gibb W. R. G. Idiopalhic Parkinson's disease and the Lewy body disorders. Neuropathology and Applied Neurobiology 1986; 12: 223–234
   PubMed Web of Science ®Google Scholar
• Gibb W. R. G. The significance of the Lewy body in the diagnosis, epidemiology, and pathogenesis of idiopathic Parkinson's disease. Thesis, University of London. 1987
   Google Scholar
• Gibb W. R. G. Neuropalhology in movement disorders. Journal of Neurology, Neurosurgery, and Psychiatry, special supplement 1989a; 55–67
   Google Scholar
• Gibb W. R. G. The diagnostic relevance of Lewy bodies and other inclusions in Parkinson's disease. Early diagnosis and preventive therapy in parkinson's disease, H. Przuntel, P. Riederer. Springer Verlag, Wien 1989b; 171–180
   Google Scholar
• Gibb W. R. G., Lees A. J. Dementia in Parkinson's disease. Lancet 1987; I: 861
   Google Scholar
• Gibb W R. G., Lees A. J., Wells F. R., Barnard R. O., Jenner P., Marsden C. D. Pathology of MPTP in the marmoset. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 187–190
   Google Scholar
• Goudsmit E., Hofman M. A., Fliers E., Swaab D. F. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age, and Alzheimer's disease. Neurobiology of Aging 1990; 11: 529–536
   PubMedGoogle Scholar
• Graham D. G., Tiffany S. M., Bell W. R. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6‐hydroxydopamine and related compounds towards C1300 neuroblastoma cells in vitro. Molecular Pharmacology 1978; 14: 644–653
   PubMed Web of Science ®Google Scholar
• Greenfield J. G., Bosanquet I. F. D. The brain‐stem lesions in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry 1953; 16: 213–226
   PubMed Web of Science ®Google Scholar
• Gross M., Bannister R., Godwin‐Austen R. Orthostatic hypotension in Parkinson's disease. Lancet 1972; 1: 174–176
   PubMed Web of Science ®Google Scholar
• Gubbay S. S., Barwick D. D. Two cases of accidental hypothermia in Parkinson's disease with unusual EEG findings. Journal of Neurology, Neurosurgery and Psychiatry 1966; 29: 459–466
   PubMed Web of Science ®Google Scholar
• Hakim A. M., Mathieson G. Basis of dementia in Parkinson's disease. Lancet 1978; 1: 729
   PubMedGoogle Scholar
• Hakim A. M., Mathieson G. Dementia in Parkinson's disease: a neuropatholoaic study. Neurology 1979; 29: 1209–1214
   PubMed Web of Science ®Google Scholar
• Hallervorden J. Anatomische Untersuchungen zur Pathogenese des postencephalilischen Parkinsonismus. Deutsche Nervenheilkunde 1935; 136: 68–77
   Google Scholar
• Hamada S., Ishii T. The Lewy body in the brain of the aged. Advances in Neurological Sciences 1963; 7: 184–186
   Google Scholar
• Heikkila R. H., Cohen G. The inhibition of H3‐Biogenic amine uptake by 5.6‐Dihydroxytryptamine: a comparison with the effects of 6‐hydroxydopamine. European Journal of Pharmacology 1971; 21: 66–69
   Google Scholar
• Hirano A. Pathology of amyotrophic lateral sclerosis. Slow, latent and temporate virus infections, D. C. Gajdusek, C. J. Gibbs, M. Alpers. NINDB monograph No. 2, U.S. Government Printing Office, Washington, D.C. 1965; 23–38
   Google Scholar
• Hirano A., Zimmerman H. M. Alzheimer's neurofibrillary changes: a topographic study. Archives of Neurology 1962; 7: 227–243
   PubMedGoogle Scholar
• Hornykiewiez O. Biochemical abnormalities in some extrastriatal neuronal systems in Parkinson's disease. Parkinson's disease‐current progress, problems and management, U. K. Rinne, M. Klinger, G. Stamm. North‐Holland Biomedical Press, Elsevier. 1980
   Google Scholar
• Hornykiewicz O., Kish S. J. Biochemical pathophysiology of Parkinson's disease. Advances in Neurology 1986; 45: 19–34
   Google Scholar
• Ishii T. Distribution of Alzheimer's neurofibrillary changes in the brainstem and hypothalamus of senile dementia. Acta Neuropathologica 1966; 6: 181–187
   PubMed Web of Science ®Google Scholar
• Ishii T. Distribution of Alzheimer's neurofibrillary changes in postencephalitic parkinsonism. Advances in Neurological Sciences 1968; 12: 909–918
   PubMedGoogle Scholar
• Javoy‐Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980; 30: 1326–1330
   PubMed Web of Science ®Google Scholar
• Javoy‐Agid F., Ruberg M., Pique L., Bertagna X., Taquet H., Studler J. M., Cesselin F., Epelbaum J., Agid Y. Biochemistry of the hypothalamus in Parkinson's disease. Neurology 1984; 34: 672–675
   PubMed Web of Science ®Google Scholar
• Jellinger K. Overview of morphological changes in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 1–18
   Google Scholar
• Jellinger K. The pathology of parkinsonism. Movement disorders, C. D. Marsden, S. Fahn. Butterworths, London 1987; 124–165
   Google Scholar
• Jellinger K., Grisold W. Cerebral atrophy in Parkinson syndrome. Experimental Brain Research 1982, suppl 5: 26–35
   PubMedGoogle Scholar
• Jellinger K., Riederer P. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intraeerebral MAO activity. Advances in Neurology 1984; 40: 199–210
   PubMedGoogle Scholar
• Jellinger K., Bancher C., Lassmann H. Cytoskeletal pathology of the Lewy bodies. Early diagnosis and preventive therapy in parkinson's disease, H. Przuntel, P. Riederer. Springer Verlag, Wien 1989; 181–189
   Google Scholar
• Joachim C. L., Morris J. M., Selkoe D. J. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Annals of Neurology 1988; 24: 50–56
   PubMed Web of Science ®Google Scholar
• Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clinical Pharmacology and Therapeutics 1971; 12: 397–406
   PubMed Web of Science ®Google Scholar
• Kopin I. J. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 137–144
   Google Scholar
• Korczyn A. D. Demenlia in Parkinson disease. Alzheimer's and parkinson' s disease. Strategies for research and development, A. Fisher, I. Hanin, C. Lachman. Plenum Press, New York 1986; 177–183
   Google Scholar
• Korczyn A. D. Autonomic nervous system screening in patients with early Parkinson's disease. Early diagnosis and preventive therapy in parkinson's disease, H. Przuntel, P. Riederer. Springer Verlag, Wien 1989; 41–48
   Google Scholar
• Kurlan R., Como P. Drug‐induced alzheimerism. Archives of Neurology 1988; 45: 356–357
   PubMedGoogle Scholar
• Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., Ihara Y. Lewy bodies are ubiquinated. Acta Neuropathologica (Berlin) 1988; 75: 345–353
   PubMed Web of Science ®Google Scholar
• Laihinen A., Rinne U. K. Function of dopamine receptors in Parkinson's disease: prolactin responses. Neurology 1986; 36: 393–395
   PubMed Web of Science ®Google Scholar
• Lang J. Surgical anatomy of the hypothalamus. Acta Neurochirurgica 1985; 75: 5–22
   PubMedGoogle Scholar
• Langston J. W., Forno L. S. The hypothalamus in parkinson disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Lawton N. F., Macdermot J. Abnormal regulation of prolactin release in idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1980; 43: 1012–1015
   PubMedGoogle Scholar
• Lee D. O. F., Markesbery W. R. The hypothalamus in senile dementia of the Alzheimer's type. Journal of Neuroputhology and Experimental Neurology 1986; 45: 341
   Web of Science ®Google Scholar
• Lesch K. P. Hypothalamic dysfunction and neuroendocrine research in Parkinson's disease. Early diagnosis and preventive therapy in parkinson's disease, H. Przuntek, P. Riederer. Spnnger‐Verlag, Wien 1989; 229–242
   Google Scholar
• Leverenz J., Sumi S. M. Parkinson's disease in patients with Alzheimer's disease. Archives of Neurology 1986; 43: 662–664
   PubMed Web of Science ®Google Scholar
• Lewy F. H. Die l'ehre vom Tonus und der Bewegung. Springer Verlag, Berlin 1923
   Google Scholar
• Lipkin L. E. Cytoplasmic inclusions in ganglion cells associated with parkinsonian states. American Journal of Pathology 1959; 35: 1117–1133
   PubMedGoogle Scholar
• Lipman I. J., Boykin M. E., Flora R. E. Glucose intolerance in Parkinson's disease. Journal of Chronic Disease 1974; 27: 573–579
   PubMedGoogle Scholar
• Lloyd K., Homykiewicz O. Parkinson's disease: activity of L‐dopa decarboxylase in discrete brain regions. Science 1970; 170: 1212–1213
   PubMedGoogle Scholar
• Malarkey W. B., Cyrus J., Paulson G. W. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L‐dopa therapy. Journal of Clinical Endocrinology and Metabolism 1974; 39: 229–235
   PubMedGoogle Scholar
• Mann D. M. A., Yates P. O. Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathologv and Applied Neurobiologv 1983; 9: 3–19
   PubMed Web of Science ®Google Scholar
• Marsden C. D. Parkinsons disease. Lancet 1990; 335: 948–952
   PubMed Web of Science ®Google Scholar
• Martignoni E., Murialdo G., Nances G., Giovale M., Nappi G., Savoldi F. Deteriorated regulation of prolactin periodicity in Parkinson's disease. Neuropeptides and psychosomatic processes, E. Endroczi. Akademiani Kiado, Budapest 1983; 661–668
   Google Scholar
• Marshall J. F., Turner B. H., Teitelhaum P. Sensory neglect produced by lateral hypothalamic damage. Science 1971; 174: 523–525
   PubMed Web of Science ®Google Scholar
• Marshall J. F., Richardson J. S., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. Journal of Comparative and Physiological Psychology 1974; 87: 808–830
   PubMedGoogle Scholar
• Martignoni E., Micieli G., Cavallini A., Pacchetti C., Magri M., Nappi G. Autonomic disorders in idiopathic parkinsonism. Journal of Neural Transmission 1986; 22: 149–161, (suppl)
   Google Scholar
• Martin W. E., Loewenson R. B., Racsch J. A., Baker A. B. Parkinson's disease: clinical analysis of 100 patients. Neurology 1973; 23: 783–790
   PubMed Web of Science ®Google Scholar
• Marttila R. J., Rinne U. K. Level of blood pressure in patients with Parkinson's disease. European Neurology 1977; 16: 73–79
   PubMedGoogle Scholar
• Marttila R. J., Eskola J., Paivarinta M., Rinne U. K. Immune functions in Parkinson's disease. Advances in neurology, R. G. Hassler, J. F. Christ. Raven Press, New York 1984; vol. 40: 315–323
   Google Scholar
• Mayeux R., Rosenstein R., Stern Y. The prevalence and risk of dementia in idiopathic Parkinson's disease. Annals of Neurology 1986; 20: 128
   Google Scholar
• Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• McDowell F. H., Lee J. E. Levodopa. Parkinson's disease and hypotension. Annals of Internal Medicine 1970; 72: 751–752
   PubMedGoogle Scholar
• McMenemey W. H. The dementias and progressive diseases of the basal ganglia. Neuropathology, J. G. Greenfield, W. Blackwood, W. H. McMenemey, A. Meyer, R. M. Norman. Edward Arnold. Ltd., London 1958
   Google Scholar
• Molsa P. K., Marttila R. J., Rinne U. K. Extrapyramidal signs in Alzheimer's disease. Neurology 1984; 34: 1114–1146
   PubMed Web of Science ®Google Scholar
• Morris J. C., Drazner M., Fulling K., Grant E. A., Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?. Archives of Neurology 1989; 46: 651–657
   PubMedGoogle Scholar
• Murri L., Iudice A., Muratorio A., Polleri A., Barreca T., Murialdo G. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea. European Neurology 1980; 19: 198–206
   PubMedGoogle Scholar
• Myers R. D. Temperature regulation: neurochemical systems in the hypothulamus. The hypothalamus, W. Haymaker, E. Anderson, W. J. H. Nauta. Charles C. Thomas, Springfield 1969; 506–523
   Google Scholar
• Nappi G., Micieli G., Martignoni E., Sandrini G., Bono G., Horowski R. Circadian and ultradian rhythms of core body temperature in Parkinson's disease. Abstracts of the XIX international congress of neurovegetative research. Berlin 1984; 307
   Google Scholar
• Nieto D., Escobar A. Major psychoses. Pathology of the nervous system, J. Minckler. McGraw‐Hill Book Co., New York 1972; vol. 3: 2654–2665
   Google Scholar
• Ohama E., Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathologica 1976; 34: 311–319
   PubMed Web of Science ®Google Scholar
• Orskov L., DuPont E., Fine Olivarius D., Christensen N. J. Autonomic function in parkinsonian patients related to duration of disease. Neurology 1987; 37: 1173–1178
   PubMed Web of Science ®Google Scholar
• Parkes J. D., Marsden C. D., Rees J. E. Parkinson's disease, cerebral arteriosclerosis and senile dementia. Quarterly Journal of Medicine 1974; 18: 49–61
   Google Scholar
• Pearce J. The extrapyramidal disorder of Alzheimer's disease. European Neurology 1974; 12: 94–103
   PubMed Web of Science ®Google Scholar
• Piha S. J., Rinne J. O., Seppanen A. Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clinical Neurology and Neurosurgery 1988; 90: 221–226
   PubMed Web of Science ®Google Scholar
• Pique L., Jegou S., Bertagna X., Javoy Agid F., Seurin D., Proeschel M. F., Girard F., Agid Y., Vaudry H., Luton J. P. Pro‐opiomelanocortin peptides in the human hypolhnlanuis: comparative study between normal subjects and Parkinson patients. Neuroscience Letters 1985; 54: 141–146
   PubMed Web of Science ®Google Scholar
• Plum F., Van Uitert R. Neuroendocrine diseases and disorders of the hypothakimus. The hypothalamus, S. Reichlin, S. Baldessarini, J. B. Martin. Raven Press, New York 1978; 415–473
   Google Scholar
• Poirier L. J. The development of animal models for studies in Parkinson's disease. Recent advances in parkinson's disease, F. H. McDowell, C. H. Markham. F. A. Davis, Philadelphia 1971; 83–117
   Google Scholar
• Price D. L., Whitehouse P. J., Struble R. G. Cellular pathology in Alzheimer's and Parkinson's diseases. Trends in Neurosciences 1986; 9: 29–33
   Google Scholar
• Rajput A. H., Ilitti R. J., Sudhakar S., Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Annals of Neurology 1989; 25: 602–606
   PubMedGoogle Scholar
• Ranson S. W. Somnotence caused by hypothalamic lesions in the monkey. Archives of Neurology and Psychiatry 1939; 41: 1–23
   Google Scholar
• Rinne U. K. Neuroendocrine and extrapyramidal dopamine neurons in Parkinson's disease. Neuroendocrinc correlates in neurology and psyichatry, E. E. Muller, A. Agnoli. North‐Holland Biomedical Press, Elsevier. 1979; 119–125
   Google Scholar
• Rinne U. K., Sonninen V. Brain Catecholamines and their metabolites m parkinsonian patients. Archives of Neurology 1973; 28: 107–110
   PubMedGoogle Scholar
• Rinne U. K., Sonninen V., Riekkinen P., Laaksonen H. Postmortem findings in Parkinsonian patients treated with L‐dopa: biochemical considerations. Current concepts in the treatment of parkinsonism, M. D. Yahr. Raven Press, New York 1974; 211–233
   Google Scholar
• Rosenberg P., Herishanu Y., Beilin B. Increased appetite (bulimia) in Parkinson's disease. Journal of the American Geriatrics Society 1977; 25: 277–278
   PubMedGoogle Scholar
• Sandyk R. Hypothalamic compensatory mechanisms in Parkinson's disease. International Journal of Neuroscience 1989; 44: 135–142
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The association of diabetes mellitus with dementia in Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Awerbuch G. I. Dysautonomia in Parkinson's disease: relationship to motor disability. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Awerbuch G. I. Autonomic functions in early stages of Parkinson's disease. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Iacono R. P., Bumford C. R. The hypothalamus in Parkinson disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P., Kay S. R. The hypothalamus in MPTP‐induced parkinsonism. Italian Journal of Neurological Sciences 1990; 11: 367–372
   PubMedGoogle Scholar
• Sano M., Stern Y., Williams J., Cote L., Rosenstein R., Mayeux R. Coexisting dementia and depression in Parkinson's disease. Archives of Neurology 1989; 46: 1284–1286
   PubMedGoogle Scholar
• Saper C. B., German D. C. Hypothalamic pathology in Alzheimer's disease. Neuroscience Letters 1987; 74: 364–370
   PubMedGoogle Scholar
• Saper C. B., German D. C., While C. L. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology 1985; 35: 1089–1095
   PubMed Web of Science ®Google Scholar
• Schope M. Uber Verandeningen im Pyramidal‐motorischen System bei einer Chorea Huntington. Zentralschrift der Gesellschafi fur Neurologie und Psychiatrie 1940; 168: 679–689
   Google Scholar
• Sechi G. P., Tanda F., Mutani R. Fatal hyperpyrexia after withdrawal of levodopa. Neurology 1984; 34: 249–251
   PubMed Web of Science ®Google Scholar
• Shuster S., Burton J. L., Thony A. J., Goolamali S. K., Burton J. L., Plurnmer N., Bates D. Melanocyte stimulating hormone and Parkinsonism. Lancet 1975; 1: 463–465
   Google Scholar
• Sim M., Sussman I. Alzheimer's disease: its natural history and differential diagnosis. Journal of Nervous and Mental Disease 1962; 135: 489–499
   PubMed Web of Science ®Google Scholar
• Singer G., Willis G. L. Biochemical and pharmacological basis for the lateral hypothalamic syndrome. Brain Research Bulletin 1977; 2: 485–489
   PubMedGoogle Scholar
• Smith G. P., Young R. C. A new experimental model of hypokinesia. Advances in Neurology 1974; 5: 427–432
   PubMedGoogle Scholar
• Sparks D. L., DeKosky S. T., Markesbery W. R. Alzheimer's disease. Aminergic‐cholinergic alterations in hypothalamus. Archives of Neurology 1988; 45: 994–999
   PubMedGoogle Scholar
• Spiegel E. A., Wycis H. T. The possible role of the hypothalamus in parkinsonian brady—and akinesia. A working hypothesis. Confinia Neurology 1967; 29: 262–264
   PubMedGoogle Scholar
• Spiegel E. A., Wycis H. T., Schor S., Schwartz M. A., Fabioni F. R. The incidence of vegetative symptoms in Parkinson patients with and without bradykinesia. Third symposium on Parkinson's disease, G. Donaldson, Livingstone 1969; 200
   Google Scholar
• Sroka H., Elizan T. S., Yahr M. D., Burger A., Mendoza M. R. Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy. Archives of Neurology 1981; 38: 339–342
   PubMedGoogle Scholar
• Stevens J. R. Neuropathology of schizophrenia. Archives of General Psychiatry 1982; 39: 1131–1139
   PubMed Web of Science ®Google Scholar
• Streifler M., Avrami E., Rabey J. L‐dopa and sebum secretion in parkinsonian patients. 11th world congress of neurology, W. A. den Hartog Jager, G. W. Bruyn, A. P. J. Heijstee. Excerpta Medica, Amsterdam 1977; 385
   Google Scholar
• Sulkava R. Alzheimer's disease and senile dementia of the Alzheimer's type: a comparative study. Acta Neurologica Scandinavica 1982; 65: 636–650
   PubMed Web of Science ®Google Scholar
• Szekely E. G., Zivanovic D., Spiegel E. A. The influence of stimulation of the hypothalamus and the dorsomedial nucleus upon experimental bradykinesia and akinesia. Journal of Neurological Sciences 1969; 90: 255–260
   Google Scholar
• Toru M., Matsuda O., Makiguchi K., Sugano K. Neuroleptic malignant syndrome‐like state following a withdrawal of antiparkinsonian drugs. Journal of Nervous and Mental Disease 1981; 169: 324–327
   PubMed Web of Science ®Google Scholar
• Turkka J. T., Myllyla V. V. Sweating dysfunction in Parkinson's disease. European Neurology 1987; 26: 1–7
   PubMedGoogle Scholar
• Turkka J. T., Tolonen U., Myllyla V. V. Cardiovascular reflexes in Parkinson's disease. European Neurology 1987; 26: 104–112
   PubMed Web of Science ®Google Scholar
• Van der Linden C., Jankovic J., Jansson B. Lateral hypothalamic dysfunction in Parkinson's disease. Annals of Neurology 1985; 18: 137–138
   Web of Science ®Google Scholar
• Van Dongen P. A. M. The human locus coeruleus in neurology and psychiatry (Parkinson's, Lewy body. Hallervorden‐Spatz, Alzheimer's and Korsakoffs disease, (pre)senile dementia, schizophrenia, affective disorders, psychosis). Progress in Neurobiology 1981; 17: 97–139
   PubMed Web of Science ®Google Scholar
• Vogels O. J. M., Broere C. A. J., Nieuwenhins R. Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease. Neuroscience Letters 1990; 109: 48–62
   PubMedGoogle Scholar
• Volpi R., Scaglioni A., Marcato A., Caffarra P., Rossi G., Caffarri G., Delsignore R., Chiodera P., Coiro V. Failure of the gamma‐aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinsons disease. Journal of Neural Transmission 1991; 4: 259–264
   Google Scholar
• Von Braunmuhl A. Alterserkrankungen des Zentranervensystems: Senile Involution: Senile Demenz: Alzheimersche Krankheit. Handbuch des speziellen pathologischen Anatomie und Histologie, O. Lubarsch, F. Henke, R. Rossle. Springer‐Verlag, Berlin 1957
   Google Scholar
• Von Buttlar‐Brentano K. Pathohistologische Feststellungen am basalkern Schizophrener. Journal of Nervous and Mental Disease 1952; 1/6: 646–653
   Google Scholar
• Von Buttlar‐Brentano K. Zur Lebensgeschichte des Nucleus basalis. tuberomammilaris, supraopticus, and paraventricularis under normalen und pathogenen Bedingungen. Journal fur Hirnforschung 1954; 1: 337–419
   Google Scholar
• Willis G. L. Amine accumulation in Parkinson's disease and other disorders. Neuroscience, & Biobehavioral Reviews 1987; 11: 97–105
   PubMed Web of Science ®Google Scholar
• Willis G. L., Sandyk R. Altered sensitivity of the lateral hypothalamic dopamine receptors in 6‐hydroxydopamine treated rats. International Journal of Neuroscience
   Google Scholar
• Willis G. L., Smith G. C. Intrahypothalamic injections of dopamine (DA) receptor antagonists reinstate locomotory and consummatory control after DA‐depleting lesions. Neuroscience Letters 1983; 15: S64, (suppl)
   Google Scholar
• Willis G. L., Smith G. C. Deficits in locomotor behavior and thermoregulation produced by intrahypothalamic dopamine injections. Behavioural Brain Research 1984a; 12: 137–143
   PubMed Web of Science ®Google Scholar
• Willis G. L., Smith G. C. A role for amine accumulation in the syndrome of ingestive deficits following lateral hypothalamic lesions. Appetite 1984b; 5: 239–262
   PubMed Web of Science ®Google Scholar
• Willis G. L., Smith G. C. Dopamine neurone degeneration‐like deficits produced by intrahypothalamic dopamine injections. Advances in behavioral biology, J. S. McKenzie, R. E. Kemm, L. Wilcock. Plenum Press. 1984c; 431–442
   Google Scholar
• Willis G. L., Smith G. C. Amine accumulation in behavioral pathology. Brain Research Reviews 1985a; 9: 109–132
   Google Scholar
• Willis G. L., Smith G. C. Catecholamine blocking drugs injected at sites of amine accumulation reverse catecholamine degeneration associated deficits. Behavioural Brain Research 1985b; 15: 101–106
   PubMed Web of Science ®Google Scholar
• Willis G. L., Smith G. C. Fluorescent hislochemical detection of injected dopamine in lateral hypothalamus after degeneration of catecholaminergic fibres. Neurochemistry International 1987; 11: 143–148
   PubMed Web of Science ®Google Scholar
• Willis G. L., Smith G. C., McGrath B. P. Deficits in locomotor behaviour and motor performance after central 6‐hydroxydopamine or peripheral L‐dopa. Brain Research 1983; 266: 279–286
   PubMed Web of Science ®Google Scholar
• Willis G. L., Savulescu J., Home M. K., Smith C. G. MPTP. impairment of motor performance and amine accumulation in Macaca fasicularis. Brain Research Bulletin 1987; 19: 57–61
   PubMedGoogle Scholar
• Willis G. L., Smith G. C., Pavey G. M., Sandyk R. Amelioration of evperimental parkinsonism by intrahypothalamic administration of haloperidol. International Journal of Neuroscience
   Google Scholar
• Woodard J. S. Concentric hyaline inclusion body formation in mental disease analysis of twenty‐seven cases. Journal of Neuropathology and Experimental Neurology 1962; 21: 442–449
   PubMed Web of Science ®Google Scholar
• Zigmond M. J., Sticker E. M. Deficits in feeding behavior after intraventricular 6‐hydroxydopamine or lateral hypothalamic lesions. Science 1972; 177: 1211–1214
   PubMedGoogle Scholar